EM Imaging, a spin-out company from the University of Edinburgh, is a clinical phase biotechnology company with a highly novel C-Met molecular targeting technology platform. It is developing a radiotherapeutic agent for treatment in cancer, alongside its fluorescent optical imaging agent.
VIEW WEBSITE >>
Location: United Kingdom, Scotland, City of Edinburgh
Investors 1
| Date | Name | Website |
| - | Epidarex C... | epidarex.c... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 22.09.2017 | Edinburgh Molecular Imaging Begins Phase II European Cancer ... | Scottish biotechnology firm Edinburgh Molecular Imaging (EM Imaging) has announced the commencement ... | digit.fyi/... |